Grifois, S.A.

GRFSNASDAQ

Market cap

$5.25B

Employees

25,247

Exchange

NASDAQ

Headquarters

Barcelona, Spain

About Grifois, S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Country

US

Website

www.grifols.com